Displaying 1 to 1 of 1 investments
Country Notes
Orpheris Inc
Clinical-stage neuroscience company leveraging a platform technology that enabling selective delivery of therapeutic agents across the blood barrier.
United States N/A
Initial investment. Round participant. Exited